Main Page

Oracle Health and Life Sciences poster presentations

We are excited to be presenting 14 poster sessions

These posters represent the breadth and depth of our research capabilities, spanning multiple countries, varied methodologies, and a range of therapeutic areas. If you'd like to learn more about partnering with Oracle to support your evidence generation needs across the drug development lifecycle, please stop by our booth to learn more.
Poster Session Discussion Period Monday, May 18th 12:30 – 1:30 p.m.

Risk of Infectious Diseases Among Older US Adults with Alzheimer’s Disease Compared with Those Without in Nursing Home and Community Settings: A Claims-Based Cohort Study Session Code: EPH22
Prevalence of Polycystic Ovary Syndrome (PCOS) and Burden of Disease Among Women Ages 18-44 in the US, National Health and Wellness Survey Session Code: EPH36
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Preferences among Patients and Cardiologists: Findings from two Advisory Boards in the United States Session Code: PCR26

Poster Session Discussion Period Tuesday, May 19th: 12:30 – 1:30 p.m.

Comparing the Disease Burden of Migraine Between Users of CGRP Monoclonal Antibodies and Preventive Gepants Session Code: PCR91
Aptitude Towards Patient-Centered Care Among Physicians Managing Rare Disease in the United States: A Cross-Sectional Survey Session Code: HSD66

Poster Session Discussion Period Tuesday, May 19th: 6:00 – 7:00 p.m.

Binary Classification Analysis for Predicting Medication Adherence among US Adults Currently Taking Prescribed Medication for Depression Session Code: MSR158
Exploring physicians’ perspectives on barriers to engaging patients with rare diseases and/or their caregivers in shared decision-making in the United States (US): findings from a cross-sectional survey Session Code: HSD93
Differences in Patient Characteristics and Outcomes by Medication Adherence among US Adults Treated for High Cholesterol Session Code: PCR121
Real-World Treatment Patterns Among People with Moderate-to-Severe Hemophilia A and B in China: A Retrospective Database Study Session Code: RWD130
Which Providers Prescribe Antivirals for COVID-19 Treatment in the US Session Code: HSD82
Curating Fit-for-Purpose Geographic Real-World Data Session Code: RWD135

Poster Session Discussion Period Wednesday, May 20th, 9:00 – 10:00 a.m.

Comparing health outcomes by Chronic Obstructive Pulmonary Disease (COPD) Status and Risk Level: Findings from the US National Health and Wellness Survey Session Code: EPH217
Comparing Outcome Modeling Strategies for Zero-Inflated Absenteeism in Real-World Data: Implications for Inference on Anxiety Severity Session Code: MSR206
Burden of Illness in CIDP: Results of a Multinational Real-World Survey Session Code: RWD135